Annual Shareholders Equity
$103.70 M
-$83.89 M-44.72%
December 31, 2023
Summary
- As of February 7, 2025, PSTX annual stockholders equity is $103.70 million, with the most recent change of -$83.89 million (-44.72%) on December 31, 2023.
- During the last 3 years, PSTX annual shareholders equity has fallen by -$158.27 million (-60.41%).
Performance
PSTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$87.21 M
+$26.39 M+43.40%
September 30, 2024
Summary
- As of February 7, 2025, PSTX quarterly stockholders equity is $87.21 million, with the most recent change of +$26.39 million (+43.40%) on September 30, 2024.
- Over the past year, PSTX quarterly shareholders equity has increased by +$26.39 million (+43.40%).
Performance
PSTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PSTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.7% | +43.4% |
| 3 y3 years | -60.4% | -41.9% |
| 5 y5 years | +235.2% | - |
PSTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.7% | at low | -59.7% | -30.3% |
| 5 y | 5-year | -60.4% | -244.2% | -70.5% | -335.4% |
| alltime | all time | -60.4% | -244.2% | -70.5% | -335.4% |
Poseida Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $87.21 M(+43.4%) |
| Jun 2024 | - | $60.82 M(-28.1%) |
| Mar 2024 | - | $84.59 M(-18.4%) |
| Dec 2023 | $103.70 M(-44.7%) | $103.70 M(-16.1%) |
| Sep 2023 | - | $123.66 M(-8.6%) |
| Jun 2023 | - | $135.30 M(-14.1%) |
| Mar 2023 | - | $157.56 M(-16.0%) |
| Dec 2022 | $187.59 M(+20.1%) | $187.59 M(-13.3%) |
| Sep 2022 | - | $216.31 M(+228.7%) |
| Jun 2022 | - | $65.80 M(-36.5%) |
| Mar 2022 | - | $103.70 M(-33.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $156.21 M(-40.4%) | $156.21 M(+4.0%) |
| Sep 2021 | - | $150.16 M(-19.5%) |
| Jun 2021 | - | $186.58 M(-18.0%) |
| Mar 2021 | - | $227.49 M(-13.2%) |
| Dec 2020 | $261.97 M(-275.2%) | $261.97 M(-11.4%) |
| Sep 2020 | - | $295.84 M(-244.1%) |
| Jun 2020 | - | -$205.30 M(-536.4%) |
| Mar 2020 | - | $47.04 M(-131.5%) |
| Dec 2019 | -$149.51 M(+94.9%) | -$149.51 M |
| Dec 2018 | -$76.72 M(+128.7%) | - |
| Dec 2017 | -$33.54 M | - |
FAQ
- What is Poseida Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Poseida Therapeutics?
- What is Poseida Therapeutics annual shareholders equity year-on-year change?
- What is Poseida Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly shareholders equity year-on-year change?
What is Poseida Therapeutics annual stockholders equity?
The current annual shareholders equity of PSTX is $103.70 M
What is the all time high annual shareholders equity for Poseida Therapeutics?
Poseida Therapeutics all-time high annual stockholders equity is $261.97 M
What is Poseida Therapeutics annual shareholders equity year-on-year change?
Over the past year, PSTX annual stockholders equity has changed by -$83.89 M (-44.72%)
What is Poseida Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PSTX is $87.21 M
What is the all time high quarterly shareholders equity for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly stockholders equity is $295.84 M
What is Poseida Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PSTX quarterly stockholders equity has changed by +$26.39 M (+43.40%)